-
-
-
-
-
-
-
Alexza Reports 2016 First Quarter Financial Results
-
-
-
-
-
-
-
Alexza Reports Fourth Quarter and Year End 2015 Financial Results
-
-
-
-
-
-
-
Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 (Staccato® alprazolam) in Epilepsy Patients
-
1,155,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

